These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16508919)

  • 1. Expression of drug pathway proteins is independent of tumour type.
    Zhang W; Shannon WD; Duncan J; Scheffer GL; Scheper RJ; McLeod HL
    J Pathol; 2006 Jun; 209(2):213-9. PubMed ID: 16508919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections.
    Wapnir IL; van de Rijn M; Nowels K; Amenta PS; Walton K; Montgomery K; Greco RS; Dohán O; Carrasco N
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1880-8. PubMed ID: 12679487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
    Wissmann C; Wild PJ; Kaiser S; Roepcke S; Stoehr R; Woenckhaus M; Kristiansen G; Hsieh JC; Hofstaedter F; Hartmann A; Knuechel R; Rosenthal A; Pilarsky C
    J Pathol; 2003 Oct; 201(2):204-12. PubMed ID: 14517837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.
    Forget MA; Turcotte S; Beauseigle D; Godin-Ethier J; Pelletier S; Martin J; Tanguay S; Lapointe R
    Br J Cancer; 2007 Feb; 96(4):646-53. PubMed ID: 17245340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan in lymphoma, leukemia, and breast, pancreatic, ovarian, and small-cell lung cancers.
    Rosen LS
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):103-9. PubMed ID: 9726101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p27kip1 in breast cancer and its prognostic significance.
    Barnes A; Pinder SE; Bell JA; Paish EC; Wencyk PM; Robertson JF; Elston CW; Ellis IO
    J Pathol; 2003 Nov; 201(3):451-9. PubMed ID: 14595757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
    Cummings J; Ethell BT; Jardine L; Burchell B
    Anticancer Res; 2006; 26(3B):2189-96. PubMed ID: 16821585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HER2 amplification using the SISH technique in breast, colon, prostate, lung and ovarian carcinoma.
    Ramieri MT; Murari R; Botti C; Pica E; Zotti G; Alo PL
    Anticancer Res; 2010 Apr; 30(4):1287-92. PubMed ID: 20530441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging mass spectrometry: principles and potentials.
    Chaurand P; Schwartz SA; Reyzer ML; Caprioli RM
    Toxicol Pathol; 2005; 33(1):92-101. PubMed ID: 15805060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical activity spectrum of irinotecan].
    Cottu PH; Extra JM; Lerebours F; Espie M; Marty M
    Bull Cancer; 1998 Dec; Spec No():21-5. PubMed ID: 9932080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan.
    Xu G; Zhang W; Ma MK; McLeod HL
    Clin Cancer Res; 2002 Aug; 8(8):2605-11. PubMed ID: 12171891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide and protein imaging mass spectrometry in cancer research.
    McDonnell LA; Corthals GL; Willems SM; van Remoortere A; van Zeijl RJ; Deelder AM
    J Proteomics; 2010 Sep; 73(10):1921-44. PubMed ID: 20510389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein.
    de Jong FA; Scott-Horton TJ; Kroetz DL; McLeod HL; Friberg LE; Mathijssen RH; Verweij J; Marsh S; Sparreboom A
    Clin Pharmacol Ther; 2007 Jan; 81(1):42-9. PubMed ID: 17185998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma.
    Doganavsargil B; Simsir A; Boyacioglu H; Cal C; Hekimgil M
    BJU Int; 2006 Mar; 97(3):644-8. PubMed ID: 16469041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
    Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.